• Ownership

David Bredt - Insider Trading & Ownership

Entity
Individual
Location
C/O Rapport Therapeutics, 1325 Boylston St., Suite 401, Boston, MA
Summary
The estimated net worth of David Bredt is at least $4.41M dollars as of April 16, 2025. David Bredt is the Chief Scientific Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $4.41M.
All Insider Reports
All Insider Reports

Ownership of David Bredt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Scientific Officer $4.41M -$174K -3.79% Apr 15, 2025

Insider Transactions Reported by David Bredt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.